Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Philadelphia, Pennsylvania 19107


Purpose:

To determine whether one glaucoma eye drop is less likely to cause changes to the surface of the eye (conjunctiva) than another. The two different prostaglandins are Xalatan and Travatan Z.


Study summary:

Two groups will be entered into this study: group 1 will be naive to treatment and group 2 will be using Xalatan for at least one month before enrollment. Both groups will be using one drop at bedtime of Xalatan in the right eye and one drop at bedtime of Travatan Z in the left eye. Both of these drops are presently on the market and approved by the FDA for treatment of lowering eye pressure. Because this study will be masked, the examining clinician will not know what study drop each patient has been using.


Criteria:

Inclusion Criteria: - Age 21 or older - Able to understand protocol and agree to 3 visits - Any type of glaucoma - Selective laser trabeculoplasty, Argon laser trabeculoplasty, peripheral iridotomy accepted - Naïve: No prior glaucoma treatment (medical or surgical) - If patient non-compliant, must be off meds 3 months - Xalatan: At least one month use Exclusion Criteria: - Both Groups: Any history of ocular surface disease - Dry eye syndrome or prior Restasis use - Prior ocular surgery other than cataract extractions - Uveitis or other inflammatory disease of the eye or adnexa - Systemic medications that might influence ocular inflammation - Any active inflammation or infection - Pregnancy or intention to become pregnant - Naïve: Prior use of topical glaucoma medication unless off for 3 months. - Use of preserved artificial tear preparations in last 30 days and more than one year history of chronic use - Xalatan: Prior use of Travatan or Travatan Z


NCT ID:

NCT00798694


Primary Contact:

Principal Investigator
Leslie J Katz, MD
Wills Eye Glaucoma Service


Backup Contact:

N/A


Location Contact:

Philadelphia, Pennsylvania 19107
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.